{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"Research Square"}],"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T16:40:45Z","timestamp":1792428045446,"version":"4.5.0"},"posted":{"date-parts":[[2026,7,1]]},"group-title":"In Review","reference-count":65,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2026,6,22]]},"abstract":"<title>Abstract<\/title>\n                <p>Progressive supranuclear palsy (PSP) is a neurodegenerative disease diagnosed according to its histopathologic pattern of tau proteinopathy (\u201ctauopathy\u201d). It is increasingly appreciated that PSP is heterogeneous in both clinical and pathological presentations. However, the prevalence of PSP subtypes, in comparison to other tauopathies, remain incompletely characterized. Here we analyzed NACC Neuropathology Data Set data aggregated from 37 U.S. Alzheimer\u2019s Disease Research Centers (ADRCs). Clinical and gold-standard neuropathologic features of autopsied participants were compared, stratifying on cognitive status at recruitment into the study. The final sample comprised 6994 individuals who were followed approximately annually for 4.0 years on average before autopsy. Among those with dementia at recruitment (n=4309), 2.9% had autopsy-confirmed corticobasal degeneration (CBD), 2.6% Pick\u2019s disease, and 4.6% PSP. By contrast, among those recruited while cognitively normal (n=1452), 0.7% had CBD, 0.1% Pick\u2019s disease, and, remarkably, 3.3% were diagnosed with PSP pathology. The relatively high frequency of PSP pathology detected among individuals recruited while cognitively normal suggests there is a subtype of PSP that is unexpectedly common in the broader population. In comparing between incident (recruited normal) and prevalent (recruited with dementia) autopsy-confirmed PSP, those with incident PSP died older (89.6 years versus 76.2 years on average). Furthermore, incident PSP pathology cases were less likely to manifest stereotypical PSP clinical features, but more likely to have parkinsonism, compared to prevalent PSP pathology cases. In a convenience sample of autopsy-confirmed PSP from the University of Kentucky ADRC (n=23), digital pathology analyses using HALO software and AI-based analytic modules revealed that PSP tau pathology was more severe in prevalent PSP, but in the putamen, incident cases had a higher proportion of tufted astrocytes and lower proportion of NFTs. In summary, incident PSP pathology is a relatively common tauopathy in older ADRC participants, often differing clinically and pathologically from prevalent PSP.<\/p>","DOI":"10.21203\/rs.3.rs-10119056\/v1","type":"posted-content","created":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T01:20:13Z","timestamp":1782868813000},"source":"Crossref","is-referenced-by-count":0,"title":["Prevalent versus incident progressive supranuclear palsy: An analysis of the frequencies of neuropathological and clinical features at U.S. Alzheimer's Disease Research Centers indicate a relatively common tauopathy of aging"],"prefix":"10.21203","author":[{"given":"Benjamin J","family":"Cushing","sequence":"first","affiliation":[{"name":"University of Kentucky"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan K.","family":"Shahidehpour","sequence":"additional","affiliation":[{"name":"University of Kentucky"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erin L.","family":"Abner","sequence":"additional","affiliation":[{"name":"University of Kentucky"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory A.","family":"Jicha","sequence":"additional","affiliation":[{"name":"University of Kentucky"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janna M.","family":"Neltner","sequence":"additional","affiliation":[{"name":"University of Kentucky"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madeline K.","family":"Breig","sequence":"additional","affiliation":[{"name":"University of Kentucky"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kailen L.","family":"Teodorescu","sequence":"additional","affiliation":[{"name":"University of Kentucky"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allison M.","family":"Neltner","sequence":"additional","affiliation":[{"name":"University of Kentucky"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elif P.","family":"Coskun","sequence":"additional","affiliation":[{"name":"University of Kentucky"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabor G.","family":"Kovacs","sequence":"additional","affiliation":[{"name":"University of Kentucky"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter T.","family":"Nelson","sequence":"additional","affiliation":[{"name":"University of Kentucky"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","unstructured":"National Alzheimers Coordinating Center (2026) The NACC Neuropathology Data Form \u2014 Version 11 https:\/\/files.alz.washington.edu\/documentation\/np11-form.pdf. Accessed May 23"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1002\/mds.27619","article-title":"Sensitivity and Specificity of Diagnostic Criteria for Progressive Supranuclear Palsy","volume":"34","author":"Ali F","year":"2019","unstructured":"Ali F, Martin PR, Botha H, Ahlskog JE, Bower JH, Masumoto JY, Maraganore D, Hassan A, Eggers S, Boeve BFet al et al (2019) Sensitivity and Specificity of Diagnostic Criteria for Progressive Supranuclear Palsy. Mov Disord 34:1144\u20131153. 10.1002\/mds.27619","journal-title":"Mov Disord"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1002\/alz.70575","article-title":"Cognitive and neuropsychological trajectories in patients with mixed neurodegenerative pathologies","volume":"21","author":"Almeida FC","year":"2025","unstructured":"Almeida FC, Marx GA, Rohde SK, Gonzales MM, Maldonado-D\u00edaz C, Hiya S, Clare K, Samanamud J, Slocum CC, Kauffman Jet al et al (2025) Cognitive and neuropsychological trajectories in patients with mixed neurodegenerative pathologies. Alzheimer's Dement 21. 10.1002\/alz.70575","journal-title":"Alzheimer's Dement"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"107109","DOI":"10.1016\/j.parkreldis.2024.107109","article-title":"Relationships between regional burden of tau pathology and age at death and disease duration in PSP","volume":"127","author":"Badihian N","year":"2024","unstructured":"Badihian N, Tosakulwong N, Weigand SD, Ali F, Clark HM, Stierwalt J, Botha H, Savica R, Dickson DW, Whitwell JL al (2024) Relationships between regional burden of tau pathology and age at death and disease duration in PSP. Parkinsonism Relat Disord 127:107109. 10.1016\/j.parkreldis.2024.107109","journal-title":"Parkinsonism Relat Disord"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1186\/s13293-026-00899-5","article-title":"Sex differences for clinical presentations and co-pathologies in four-repeat tauopathies","volume":"17","author":"Bayram E","year":"2026","unstructured":"Bayram E, Carter DJ, Aslam S, Forbes E, Holden SK (2026) Sex differences for clinical presentations and co-pathologies in four-repeat tauopathies. Biology Sex Differences 17. 10.1186\/s13293-026-00899-5","journal-title":"Biology Sex Differences"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.3233\/jad-180141","article-title":"Differences Between Women and Men in Incidence Rates of Dementia and Alzheimer\u2019s Disease","volume":"64","author":"Beam CR","year":"2018","unstructured":"Beam CR, Kaneshiro C, Jang JY, Reynolds CA, Pedersen NL, Gatz M (2018) Differences Between Women and Men in Incidence Rates of Dementia and Alzheimer\u2019s Disease. J Alzheimer\u2019s Disease 64:1077\u20131083. 10.3233\/jad-180141","journal-title":"J Alzheimer\u2019s Disease"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1097\/WAD.0b013e318142774e","article-title":"The National Alzheimer's Coordinating Center (NACC) database: the Uniform Data Set","volume":"21","author":"Beekly DL","year":"2007","unstructured":"Beekly DL, Ramos EM, Lee WW, Deitrich WD, Jacka ME, Wu J, Hubbard JL, Koepsell TD, Morris JC, Kukull WAet al et al (2007) The National Alzheimer's Coordinating Center (NACC) database: the Uniform Data Set. Alzheimer Dis Assoc Disord 21:249\u2013258. 10.1097\/WAD.0b013e318142774e","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"ref8","first-page":"270","article-title":"The National Alzheimer's Coordinating Center (NACC) Database: an Alzheimer disease database","volume":"18","author":"Beekly DL","year":"2004","unstructured":"Beekly DL, Ramos EM, van Belle G, Deitrich W, Clark AD, Jacka ME, Kukull WA (2004) The National Alzheimer's Coordinating Center (NACC) Database: an Alzheimer disease database. Alzheimer Dis Assoc Disord 18:270\u2013277","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1093\/jnen\/nly049","article-title":"The Revised National Alzheimer\u2019s Coordinating Center\u2019s Neuropathology Form\u2014Available Data and New Analyses","volume":"77","author":"Besser LM","year":"2018","unstructured":"Besser LM, Kukull WA, Teylan MA, Bigio EH, Cairns NJ, Kofler JK, Montine TJ, Schneider JA, Nelson PT (2018) The Revised National Alzheimer\u2019s Coordinating Center\u2019s Neuropathology Form\u2014Available Data and New Analyses. J Neuropathology Experimental Neurol 77:717\u2013726. 10.1093\/jnen\/nly049","journal-title":"J Neuropathology Experimental Neurol"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/bf00308809","article-title":"Neuropathological stageing of Alzheimer-related changes","volume":"82","author":"Braak H","year":"1991","unstructured":"Braak H, Braak E (1991) Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 82:239\u2013259. 10.1007\/bf00308809","journal-title":"Acta Neuropathol"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1093\/jnen\/nlac094","article-title":"Digital Histological Study of Neocortical Grey and White Matter Tau Burden Across Tauopathies","volume":"81","author":"Coughlin DG","year":"2022","unstructured":"Coughlin DG, Hiniker A, Peterson C, Kim Y, Arezoumandan S, Giannini L, Pizzo D, Weintraub D, Siderowf A, Litvan I al (2022) Digital Histological Study of Neocortical Grey and White Matter Tau Burden Across Tauopathies. J Neuropathology Experimental Neurol 81:953\u2013964. 10.1093\/jnen\/nlac094","journal-title":"J Neuropathology Experimental Neurol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1212\/wnl.0000000000002638","author":"Coyle-Gilchrist ITS","year":"2016","unstructured":"Coyle-Gilchrist ITS, Dick KM, Patterson K, V\u00e1zquez Rodr\u00edquez P, Wehmann E, Wilcox A, Lansdall CJ, Dawson KE, Wiggins J, Mead S et al (2016) Prevalence, characteristics, and survival of frontotemporal lobar degeneration syndromes. Neurology 86: 1736\u20131743 10.1212\/wnl.0000000000002638"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"II6","DOI":"10.1007\/bf03161076","article-title":"Neuropathologic differentiation of progressive supranuclear palsy and corticobasal degeneration","volume":"246","author":"Dickson DW","year":"1999","unstructured":"Dickson DW (1999) Neuropathologic differentiation of progressive supranuclear palsy and corticobasal degeneration. J Neurol 246:II6\u2013II15. 10.1007\/bf03161076","journal-title":"J Neurol"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1093\/jnen\/nlad025","article-title":"Atri A (2023) Low clinical sensitivity and unexpectedly high incidence for neuropathologically diagnosed progressive supranuclear palsy","volume":"82","author":"Driver-Dunckley ED","unstructured":"Driver-Dunckley ED, Zhang N, Serrano GE, Dunckley NA, Sue LI, Shill HA, Mehta SH, Belden C, Tremblay C Atri A (2023) Low clinical sensitivity and unexpectedly high incidence for neuropathologically diagnosed progressive supranuclear palsy. J Neuropathology Experimental Neurol 82: 438\u2013451 10.1093\/jnen\/nlad025","journal-title":"J Neuropathology Experimental Neurol"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/j.parkreldis.2011.02.017","article-title":"Neuropathological findings of PSP in the elderly without clinical PSP: Possible incidental PSP?","volume":"17","author":"Evidente VGH","year":"2011","unstructured":"Evidente VGH, Adler CH, Sabbagh MN, Connor DJ, Hentz JG, Caviness JN, Sue LI, Beach TG (2011) Neuropathological findings of PSP in the elderly without clinical PSP: Possible incidental PSP? Parkinsonism Relat Disord 17:365\u2013371. 10.1016\/j.parkreldis.2011.02.017","journal-title":"Parkinsonism Relat Disord"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1002\/alz.13422","article-title":"Different cohort, disparate results: Selection bias is a key factor in autopsy cohorts","volume":"20","author":"Gauthreaux K","year":"2024","unstructured":"Gauthreaux K, Kukull WA, Nelson KB, Mock C, Chen YC, Chan KCG, Fardo DW, Katsumata Y, Abner EL, Nelson PT (2024) Different cohort, disparate results: Selection bias is a key factor in autopsy cohorts. Alzheimer's Dement 20:266\u2013277. 10.1002\/alz.13422","journal-title":"Alzheimer's Dement"},{"key":"ref17","first-page":"49","volume-title":"Progressive supranuclear palsy","author":"Giagkou N","year":"2019","unstructured":"Giagkou N, G\u00fcnter, Stamelou M (2019) Progressive supranuclear palsy. Elsevier, City, pp 49\u201386"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1016\/s0021-9258(18)48531-6","article-title":"Hydrofluoric acid-treated tau PHF proteins display the same biochemical properties as normal tau","volume":"267","author":"Greenberg SG","year":"1992","unstructured":"Greenberg SG, Davies P, Schein JD, Binder LI (1992) Hydrofluoric acid-treated tau PHF proteins display the same biochemical properties as normal tau. J Biol Chem 267:564\u2013569. 10.1016\/s0021-9258(18)48531-6","journal-title":"J Biol Chem"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.parkreldis.2021.01.015","article-title":"Marti MJ (2021) Association of PSP phenotypes with survival: A brain-bank study","volume":"84","author":"Guasp M","unstructured":"Guasp M, Molina-Porcel L, Painous C, Caballol N, Camara A, Perez-Soriano A, S\u00e1nchez-G\u00f3mez A, Garrido A, Mu\u00f1oz E Marti MJ (2021) Association of PSP phenotypes with survival: A brain-bank study. Parkinsonism Relat Disord 84: 77\u201381 10.1016\/j.parkreldis.2021.01.015","journal-title":"Parkinsonism Relat Disord"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"2015","DOI":"10.1212\/wnl.44.11.2015","article-title":"Preliminary NINDS neuropathologic criteria for Steele-Richardson\u2010Olszewski syndrome (progressive supranuclear palsy)","volume":"44","author":"Hauw JJ","year":"1994","unstructured":"Hauw JJ, Daniel SE, Dickson D, Horoupian DS, Jellinger K, Lantos PL, McKee A, Tabaton M, Litvan I (1994) Preliminary NINDS neuropathologic criteria for Steele-Richardson\u2010Olszewski syndrome (progressive supranuclear palsy). Neurology 44:2015\u20132015. 10.1212\/wnl.44.11.2015","journal-title":"Neurology"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1002\/mds.26987","author":"H\u00f6glinger GU","year":"2017","unstructured":"H\u00f6glinger GU, Respondek G, Stamelou M, Kurz C, Josephs KA, Lang AE, Mollenhauer B, M\u00fcller U, Nilsson C, Whitwell JL et al (2017) Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteria. Movement Disorders 32: 853\u2013864 10.1002\/mds.26987"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1159\/000121388","article-title":"Different Tau Pathology Pattern in Two Clinical Phenotypes of Progressive Supranuclear Palsy","volume":"5","author":"Jellinger KA","year":"2008","unstructured":"Jellinger KA (2008) Different Tau Pathology Pattern in Two Clinical Phenotypes of Progressive Supranuclear Palsy. Neurodegenerative Dis 5:339\u2013346. 10.1159\/000121388","journal-title":"Neurodegenerative Dis"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.parkreldis.2005.08.007","article-title":"The relationship between histopathological features of progressive supranuclear palsy and disease duration","volume":"12","author":"Josephs KA","year":"2006","unstructured":"Josephs KA, Mandrekar JN, Dickson DW (2006) The relationship between histopathological features of progressive supranuclear palsy and disease duration. Parkinsonism Relat Disord 12:109\u2013112. 10.1016\/j.parkreldis.2005.08.007","journal-title":"Parkinsonism Relat Disord"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1016\/s1474-4422(21)00283-0","article-title":"Neuropathology of progressive supranuclear palsy after treatment with tilavonemab","volume":"20","author":"Koga S","year":"2021","unstructured":"Koga S, Dickson DW, Wszolek ZK (2021) Neuropathology of progressive supranuclear palsy after treatment with tilavonemab. Lancet Neurol 20:786\u2013787. 10.1016\/s1474-4422(21)00283-0","journal-title":"Lancet Neurol"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1093\/jnen\/nlab005","article-title":"Deep Learning-Based Image Classification in Differentiating Tufted Astrocytes, Astrocytic Plaques, and Neuritic Plaques","volume":"80","author":"Koga S","year":"2021","unstructured":"Koga S, Ghayal NB, Dickson DW (2021) Deep Learning-Based Image Classification in Differentiating Tufted Astrocytes, Astrocytic Plaques, and Neuritic Plaques. J Neuropathology Experimental Neurol 80:306\u2013312. 10.1093\/jnen\/nlab005","journal-title":"J Neuropathology Experimental Neurol"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1111\/nan.12759","article-title":"Deep learning-based model for diagnosing Alzheimer's disease and tauopathies","volume":"48","author":"Koga S","year":"2022","unstructured":"Koga S, Ikeda A, Dickson DW (2022) Deep learning-based model for diagnosing Alzheimer's disease and tauopathies. Neuropathol Appl Neurobiol 48. 10.1111\/nan.12759","journal-title":"Neuropathol Appl Neurobiol"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1111\/nan.12710","article-title":"Machine learning-based decision tree classifier for the diagnosis of progressive supranuclear palsy and corticobasal degeneration","volume":"47","author":"Koga S","year":"2021","unstructured":"Koga S, Zhou X, Dickson DW (2021) Machine learning-based decision tree classifier for the diagnosis of progressive supranuclear palsy and corticobasal degeneration. Neuropathol Appl Neurobiol 47:931\u2013941. 10.1111\/nan.12710","journal-title":"Neuropathol Appl Neurobiol"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"106076","DOI":"10.1016\/j.parkreldis.2024.106076","article-title":"Correlation between clinical and neuropathological subtypes of progressive supranuclear palsy","volume":"127","author":"Koizumi R","year":"2024","unstructured":"Koizumi R, Akagi A, Riku Y, Miyahara H, Sone J, Tanaka F, Yoshida M, Iwasaki Y (2024) Correlation between clinical and neuropathological subtypes of progressive supranuclear palsy. Parkinsonism Relat Disord 127:106076. 10.1016\/j.parkreldis.2024.106076","journal-title":"Parkinsonism Relat Disord"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/s00401-020-02158-2","article-title":"Distribution patterns of tau pathology in progressive supranuclear palsy","volume":"140","author":"Kovacs GG","year":"2020","unstructured":"Kovacs GG, Lukic MJ, Irwin DJ, Arzberger T, Respondek G, Lee EB, Coughlin D, Giese A, Grossman M, Kurz Cet al et al (2020) Distribution patterns of tau pathology in progressive supranuclear palsy. Acta Neuropathol 140:99\u2013119. 10.1007\/s00401-020-02158-2","journal-title":"Acta Neuropathol"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1007\/s00401-013-1157-y","article-title":"Non-Alzheimer neurodegenerative pathologies and their combinations are more frequent than commonly believed in the elderly brain: a community-based autopsy series","volume":"126","author":"Kovacs GG","year":"2013","unstructured":"Kovacs GG, Milenkovic I, W\u00f6hrer A, H\u00f6ftberger R, Gelpi E, Haberler C, H\u00f6nigschnabl S, Reiner-Concin A, Heinzl H, Jungwirth Set al et al (2013) Non-Alzheimer neurodegenerative pathologies and their combinations are more frequent than commonly believed in the elderly brain: a community-based autopsy series. Acta Neuropathol 126:365\u2013384. 10.1007\/s00401-013-1157-y","journal-title":"Acta Neuropathol"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1002\/alz.12509","article-title":"Black and White individuals differ in dementia prevalence, risk factors, and symptomatic presentation","volume":"18","author":"Lennon JC","year":"2022","unstructured":"Lennon JC, Aita SL, Bene VAD, Rhoads T, Resch ZJ, Eloi JM, Walker KA (2022) Black and White individuals differ in dementia prevalence, risk factors, and symptomatic presentation. Alzheimer's Dement 18:1461\u20131471. 10.1002\/alz.12509","journal-title":"Alzheimer's Dement"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1097\/00005072-199601000-00010","article-title":"Validity and reliability of the preliminary NINDS neuropathologic criteria for progressive supranuclear palsy and related disorders","volume":"55","author":"Litvan I","year":"1996","unstructured":"Litvan I, Hauw JJ, Bartko JJ, Lantos PL, Daniel SE, Horoupian DS, McKee A, Dickson D, Bancher C, Tabaton M al (1996) Validity and reliability of the preliminary NINDS neuropathologic criteria for progressive supranuclear palsy and related disorders. J Neuropathol Exp Neurol 55:97\u2013105. 10.1097\/00005072-199601000-00010","journal-title":"J Neuropathol Exp Neurol"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"4451","DOI":"10.1007\/s00415-023-11791-2","article-title":"The prevalence and incidence of progressive supranuclear palsy and corticobasal syndrome: a systematic review and meta-analysis","volume":"270","author":"Lyons S","year":"2023","unstructured":"Lyons S, Tr\u00e9pel D, Lynch T, Walsh R, O\u2019Dowd S (2023) The prevalence and incidence of progressive supranuclear palsy and corticobasal syndrome: a systematic review and meta-analysis. J Neurol 270:4451\u20134465. 10.1007\/s00415-023-11791-2","journal-title":"J Neurol"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"2070","DOI":"10.1212\/wnl.0000000000001595","article-title":"Occupational attainment influences survival in autopsy-confirmed frontotemporal degeneration","volume":"84","author":"Massimo L","year":"2015","unstructured":"Massimo L, Zee J, Xie SX, McMillan CT, Rascovsky K, Irwin DJ, Kolanowski A, Grossman M (2015) Occupational attainment influences survival in autopsy-confirmed frontotemporal degeneration. Neurology 84:2070\u20132075. 10.1212\/wnl.0000000000001595","journal-title":"Neurology"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1212\/wnl.41.4.479","article-title":"The Consortium to Establish a Registry for Alzheimer's Disease (CERAD)","volume":"41","author":"Mirra SS","year":"1991","unstructured":"Mirra SS, Heyman A, McKeel D, Sumi SM, Crain BJ, Brownlee LM, Vogel FS, Hughes JP, Belle GV, Berg L (1991) The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Neurology 41:479\u2013479. 10.1212\/wnl.41.4.479","journal-title":"Neurology"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1016\/j.hroo.2025.05.020","article-title":"Trends and differences in the rates of autopsy in the United States, 2003 to 2020: A nationwide analysis","volume":"2 6","author":"Nelson DM","year":"2025","unstructured":"Nelson DM, Rowe SJ, Trytell A, Fahy L, Freedman K, Pflaumer A, Stub D, La Gerche A, Paratz ED (2025) Trends and differences in the rates of autopsy in the United States, 2003 to 2020: A nationwide analysis. Heart Rhythm O 2 6:1165\u20131174. 10.1016\/j.hroo.2025.05.020","journal-title":"Heart Rhythm O"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1093\/jnen\/nlag035","article-title":"Locus coeruleus TDP-43 pathology in a community-based cohort: Clinical and pathological correlates","author":"Neltner AM","year":"2026","unstructured":"Neltner AM, Shahidehpour RK, Hall ME, Ning X, Fister S, Kang H, Anderson S, Jicha GA, Lee TL, Abner EL al (2026) Locus coeruleus TDP-43 pathology in a community-based cohort: Clinical and pathological correlates. J Neuropathology Experimental Neurology: Doi. 10.1093\/jnen\/nlag035","journal-title":"J Neuropathology Experimental Neurology: Doi"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1097\/nen.0b013e3182768de4","article-title":"Digital Pathology and Image Analysis for Robust High-Throughput Quantitative Assessment of Alzheimer Disease Neuropathologic Changes","volume":"71","author":"Neltner JH","year":"2012","unstructured":"Neltner JH, Abner EL, Schmitt FA, Denison SK, Anderson S, Patel E, Nelson PT (2012) Digital Pathology and Image Analysis for Robust High-Throughput Quantitative Assessment of Alzheimer Disease Neuropathologic Changes. J Neuropathology Experimental Neurol 71:1075\u20131085. 10.1097\/nen.0b013e3182768de4","journal-title":"J Neuropathology Experimental Neurol"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1272\/jnms.82.266","article-title":"Early Stage of Progressive Supranuclear Palsy: A Neuropathological Study of 324 Consecutive Autopsy Cases","volume":"82","author":"Nogami A","year":"2015","unstructured":"Nogami A, Yamazaki M, Saito Y, Hatsuta H, Sakiyama Y, Takao M, Kimura K, Murayama S (2015) Early Stage of Progressive Supranuclear Palsy: A Neuropathological Study of 324 Consecutive Autopsy Cases. J Nippon Med School 82:266\u2013273. 10.1272\/jnms.82.266","journal-title":"J Nippon Med School"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"c17","DOI":"10.1159\/000286345","article-title":"Measures of Disease Frequency: Prevalence and Incidence","volume":"115","author":"Noordzij M","year":"2010","unstructured":"Noordzij M, Dekker FW, Zoccali C, Jager KJ (2010) Measures of Disease Frequency: Prevalence and Incidence. Nephron Clin Pract 115:c17\u2013c20. 10.1159\/000286345","journal-title":"Nephron Clin Pract"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1093\/braincomms\/fcae113","article-title":"Schwarz CG (2024) Histologic tau lesions and magnetic resonance imaging biomarkers differ across two progressive supranuclear palsy variants","volume":"6","author":"Orlandi F","unstructured":"Orlandi F, Carlos AF, Ali F, Clark HM, Duffy JR, Utianski RL, Botha H, Machulda MM, Stephens YC Schwarz CG (2024) Histologic tau lesions and magnetic resonance imaging biomarkers differ across two progressive supranuclear palsy variants. Brain Commun 6: 10.1093\/braincomms\/fcae113","journal-title":"Brain Commun"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1186\/s40478-023-01674-y","article-title":"Accurate digital quantification of tau pathology in progressive supranuclear palsy","volume":"11","author":"Pansuwan T","year":"2023","unstructured":"Pansuwan T, Quaegebeur A, Kaalund SS, Hidari E, Briggs M, Rowe JB, Rittman T (2023) Accurate digital quantification of tau pathology in progressive supranuclear palsy. Acta Neuropathol Commun 11. 10.1186\/s40478-023-01674-y","journal-title":"Acta Neuropathol Commun"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1002\/mds.27872","article-title":"Validation of the Movement Disorder Society Criteria for the Diagnosis of 4-Repeat Tauopathies","volume":"35","author":"Respondek G","year":"2020","unstructured":"Respondek G, Grimm MJ, Piot I, Arzberger T, Compta Y, Englund E, Ferguson LW, Gelpi E, Roeber S, Giese Aet al et al (2020) Validation of the Movement Disorder Society Criteria for the Diagnosis of 4-Repeat Tauopathies. Mov Disord 35:171\u2013176. 10.1002\/mds.27872","journal-title":"Mov Disord"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1002\/mds.27034","author":"Respondek G","year":"2017","unstructured":"Respondek G, Kurz C, Arzberger T, Compta Y, Englund E, Ferguson LW, Gelpi E, Giese A, Irwin DJ, Meissner WG et al (2017) Which ante mortem clinical features predict progressive supranuclear palsy pathology? Movement Disorders 32: 995\u20131005 10.1002\/mds.27034"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"1758","DOI":"10.1002\/mds.26054","article-title":"The phenotypic spectrum of progressive supranuclear palsy: A retrospective multicenter study of 100 definite cases","volume":"29","author":"Respondek G","year":"2014","unstructured":"Respondek G, Stamelou M, Kurz C, Ferguson LW, Rajput A, Chiu WZ, Van Swieten JC, Troakes C, Al Sarraj S, Gelpi Eet al et al (2014) The phenotypic spectrum of progressive supranuclear palsy: A retrospective multicenter study of 100 definite cases. Mov Disord 29:1758\u20131766. 10.1002\/mds.26054","journal-title":"Mov Disord"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1002\/mdc3.12104","article-title":"Clinical Features of Patients with Concomitant Parkinson's Disease and Progressive Supranuclear Palsy Pathology","volume":"2","author":"Rigby HB","year":"2015","unstructured":"Rigby HB, Dugger BN, Hentz JG, Adler CH, Beach TG, Shill HA, Driver-Dunckley E, Sabbagh MN, Sue LI, Caviness JN (2015) Clinical Features of Patients with Concomitant Parkinson's Disease and Progressive Supranuclear Palsy Pathology. Mov Disorders Clin Pract 2:33\u201338. 10.1002\/mdc3.12104","journal-title":"Mov Disorders Clin Pract"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1007\/s00401-022-02479-4","article-title":"Rainwater Charitable Foundation criteria for the neuropathologic diagnosis of progressive supranuclear palsy","volume":"144","author":"Roemer SF","year":"2022","unstructured":"Roemer SF, Grinberg LT, Crary JF, Seeley WW, McKee AC, Kovacs GG, Beach TG, Duyckaerts C, Ferrer IA, Gelpi Eet al et al (2022) Rainwater Charitable Foundation criteria for the neuropathologic diagnosis of progressive supranuclear palsy. Acta Neuropathol 144:603\u2013614. 10.1007\/s00401-022-02479-4","journal-title":"Acta Neuropathol"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"101644","DOI":"10.1016\/j.pneurobio.2019.101644","article-title":"Schweyer K (2019) Four-repeat tauopathies","volume":"180","author":"R\u00f6sler TW","unstructured":"R\u00f6sler TW, Tayaranian Marvian A, Brendel M, Nyk\u00e4nen N-P, H\u00f6llerhage M, Schwarz SC, Hopfner F, Koeglsperger T, Respondek G Schweyer K (2019) Four-repeat tauopathies. Prog Neurobiol 180: 101644 10.1016\/j.pneurobio.2019.101644","journal-title":"Prog Neurobiol"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1002\/mds.27816","article-title":"Neuropathologic basis of frontotemporal dementia in progressive supranuclear palsy","volume":"34","author":"Sakae N","year":"2019","unstructured":"Sakae N, Josephs KA, Litvan I, Murray ME, Duara R, Uitti RJ, Wszolek ZK, Graff-Radford NR, Dickson DW (2019) Neuropathologic basis of frontotemporal dementia in progressive supranuclear palsy. Mov Disord 34:1655\u20131662. 10.1002\/mds.27816","journal-title":"Mov Disord"},{"key":"ref50","doi-asserted-by":"publisher","first-page":"120718","DOI":"10.1016\/j.jns.2023.120718","article-title":"Neuropathological analysis of cognitive impairment in progressive supranuclear palsy","volume":"451","author":"Sakuwa M","year":"2023","unstructured":"Sakuwa M, Adachi T, Suzuki Y, Takigawa H, Hanajima R (2023) Neuropathological analysis of cognitive impairment in progressive supranuclear palsy. J Neurol Sci 451:120718. 10.1016\/j.jns.2023.120718","journal-title":"J Neurol Sci"},{"key":"ref51","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1007\/s00415-011-6205-8","article-title":"The relationship between clinical and pathological variables in Richardson\u2019s syndrome","volume":"259","author":"Schofield EC","year":"2012","unstructured":"Schofield EC, Hodges JR, Bak TH, Xuereb JH, Halliday GM (2012) The relationship between clinical and pathological variables in Richardson\u2019s syndrome. J Neurol 259:482\u2013490. 10.1007\/s00415-011-6205-8","journal-title":"J Neurol"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.1111\/bpa.70102","author":"Shahidehpour RK","year":"2026","unstructured":"Shahidehpour RK, Neltner AM, Klusty MA, Corbett C, Gonzalez AD, Gutman DA, Fardo DW, Bachstetter AD, Bumgardner C, Flanagan ME et al (2026) Data-driven thresholds for standardized classification of severe Alzheimer's disease neuropathology using digital neuropathology. Brain Pathology: 10.1111\/bpa.70102"},{"key":"ref53","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.parkreldis.2019.10.012","article-title":"Are the International Parkinson disease and Movement Disorder Society progressive supranuclear palsy (IPMDS-PSP) diagnostic criteria accurate enough to differentiate common PSP phenotypes?","volume":"69","author":"Shoeibi A","year":"2019","unstructured":"Shoeibi A, Litvan I, Juncos JL, Bordelon Y, Riley D, Standaert D, Reich SG, Shprecher D, Hall D, Marras C al (2019) Are the International Parkinson disease and Movement Disorder Society progressive supranuclear palsy (IPMDS-PSP) diagnostic criteria accurate enough to differentiate common PSP phenotypes? Parkinsonism Relat Disord 69:34\u201339. 10.1016\/j.parkreldis.2019.10.012","journal-title":"Parkinsonism Relat Disord"},{"key":"ref54","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1002\/mds.27778","article-title":"Sensitivity and specificity of diagnostic criteria for progressive supranuclear palsy","volume":"34","author":"Stamelou M","year":"2019","unstructured":"Stamelou M (2019) Sensitivity and specificity of diagnostic criteria for progressive supranuclear palsy. Mov Disord 34:1087\u20131088. 10.1002\/mds.27778","journal-title":"Mov Disord"},{"key":"ref55","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1001\/archneur.1964.00460160003001","article-title":"Progressive Supranuclear Palsy","volume":"10","author":"Steele JC","year":"1964","unstructured":"Steele JC (1964) Progressive Supranuclear Palsy. Arch Neurol 10:333. 10.1001\/archneur.1964.00460160003001","journal-title":"Arch Neurol"},{"key":"ref56","doi-asserted-by":"publisher","first-page":"3464","DOI":"10.1007\/s00415-023-11629-x","article-title":"The evolution of diagnosis from symptom onset to death in progressive supranuclear palsy (PSP) and corticobasal degeneration (CBD) compared to Parkinson\u2019s disease (PD)","volume":"270","author":"Swallow DMA","year":"2023","unstructured":"Swallow DMA, Counsell CE (2023) The evolution of diagnosis from symptom onset to death in progressive supranuclear palsy (PSP) and corticobasal degeneration (CBD) compared to Parkinson\u2019s disease (PD). J Neurol 270:3464\u20133474. 10.1007\/s00415-023-11629-x","journal-title":"J Neurol"},{"key":"ref57","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.1212\/wnl.58.12.1791","article-title":"Phases of A\u03b2-deposition in the human brain and its relevance for the development of AD","volume":"58","author":"Thal DR","year":"2002","unstructured":"Thal DR, R\u00fcB U, Orantes M, Braak H (2002) Phases of A\u03b2-deposition in the human brain and its relevance for the development of AD. Neurology 58:1791\u20131800. 10.1212\/wnl.58.12.1791","journal-title":"Neurology"},{"key":"ref58","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1007\/s00702-014-1360-6","article-title":"Frontotemporal lobar degeneration FTLD-tau: preclinical lesions, vascular, and Alzheimer-related co-pathologies","volume":"122","author":"Thal DR","year":"2015","unstructured":"Thal DR, Von Arnim CAF, Griffin WST, Mrak RE, Walker L, Attems J, Arzberger T (2015) Frontotemporal lobar degeneration FTLD-tau: preclinical lesions, vascular, and Alzheimer-related co-pathologies. J Neural Transm 122:1007\u20131018. 10.1007\/s00702-014-1360-6","journal-title":"J Neural Transm"},{"key":"ref59","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-026-13742-z","article-title":"Early clinical characteristics of pathologically confirmed progressive supranuclear palsy and corticobasal degeneration","volume":"273","author":"Ting SKS","year":"2026","unstructured":"Ting SKS, Asahara Thio S, Cao K, Hameed S, Li W, Mukesh Shah J, Lin S, Sim J, Chiew HJ, Ng KPet al et al (2026) Early clinical characteristics of pathologically confirmed progressive supranuclear palsy and corticobasal degeneration. J Neurol 273. 10.1007\/s00415-026-13742-z","journal-title":"J Neurol"},{"key":"ref60","doi-asserted-by":"publisher","first-page":"83","DOI":"10.14283\/jpad.2022.81","article-title":"Socioeconomic Status and Risks of Cognitive Impairment and Dementia: A Systematic Review and Meta-Analysis of 39 Prospective Studies","volume":"10","author":"Wang AY","year":"2023","unstructured":"Wang AY, Hu HY, Ou YN, Wang ZT, Ma YH, Tan L, Yu J-T (2023) Socioeconomic Status and Risks of Cognitive Impairment and Dementia: A Systematic Review and Meta-Analysis of 39 Prospective Studies. J Prev Alzheimer's Disease 10:83\u201394. 10.14283\/jpad.2022.81","journal-title":"J Prev Alzheimer's Disease"},{"key":"ref61","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1093\/brain\/awh488","article-title":"Characteristics of two distinct clinical phenotypes in pathologically proven progressive supranuclear palsy: Richardson's syndrome and PSP-parkinsonism","volume":"128","author":"Williams DR","year":"2005","unstructured":"Williams DR, De Silva R, Paviour DC, Pittman A, Watt HC, Kilford L, Holton JL, Revesz T, Lees AJ (2005) Characteristics of two distinct clinical phenotypes in pathologically proven progressive supranuclear palsy: Richardson's syndrome and PSP-parkinsonism. Brain 128:1247\u20131258. 10.1093\/brain\/awh488","journal-title":"Brain"},{"key":"ref62","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.1093\/brain\/awm104","article-title":"Pathological tau burden and distribution distinguishes progressive supranuclear palsy-parkinsonism from Richardson's syndrome","volume":"130","author":"Williams DR","year":"2007","unstructured":"Williams DR, Holton JL, Strand C, Pittman A, De Silva R, Lees AJ, Revesz T (2007) Pathological tau burden and distribution distinguishes progressive supranuclear palsy-parkinsonism from Richardson's syndrome. Brain 130:1566\u20131576. 10.1093\/brain\/awm104","journal-title":"Brain"},{"key":"ref63","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/0304-3940(92)90145-W","article-title":"Appearance of paired nucleated, Tau-positive glia in patients with progressive supranuclear palsy brain tissue","volume":"135","author":"Yamada T","year":"1992","unstructured":"Yamada T, McGeer PL, McGeer EG (1992) Appearance of paired nucleated, Tau-positive glia in patients with progressive supranuclear palsy brain tissue. Neurosci Lett 135:99\u2013102 Doi 10.1016\/0304\u20133940(92)90145-w","journal-title":"Neurosci Lett"},{"key":"ref64","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1007\/s00401-016-1665-7","article-title":"Incipient progressive supranuclear palsy is more common than expected and may comprise clinicopathological subtypes: a forensic autopsy series","volume":"133","author":"Yoshida K","year":"2017","unstructured":"Yoshida K, Hata Y, Kinoshita K, Takashima S, Tanaka K, Nishida N (2017) Incipient progressive supranuclear palsy is more common than expected and may comprise clinicopathological subtypes: a forensic autopsy series. Acta Neuropathol 133:809\u2013823. 10.1007\/s00401-016-1665-7","journal-title":"Acta Neuropathol"},{"key":"ref65","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2377-6-2","article-title":"Population-based neuropathological studies of dementia: design, methods and areas of investigation \u2013 a systematic review","volume":"6","author":"Zaccai J","year":"2006","unstructured":"Zaccai J, Ince P, Brayne C (2006) Population-based neuropathological studies of dementia: design, methods and areas of investigation \u2013 a systematic review. BMC Neurol 6. 10.1186\/1471-2377-6-2","journal-title":"BMC Neurol"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/www.researchsquare.com\/article\/rs-10119056\/v1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.researchsquare.com\/article\/rs-10119056\/v1.html","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T16:01:34Z","timestamp":1792425694000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.researchsquare.com\/article\/rs-10119056\/v1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,1]]},"references-count":65,"URL":"https:\/\/doi.org\/10.21203\/rs.3.rs-10119056\/v1","relation":{"is-preprint-of":[{"id-type":"doi","id":"10.1007\/s00401-026-03100-8","asserted-by":"subject"}]},"subject":[],"published":{"date-parts":[[2026,7,1]]},"subtype":"preprint"}}